(marketscreener.com) MONTRÉAL, March 14, 2024 -- IBEX Technologies Inc. announces that it has filed an addendum to its management proxy circular dated February 23, 2024 for the annual and special meeting of shareholders to be held in Montreal, Québec on April 3, 2024. The addendum is available on IBEX's website at www.ibex.ca and...https://www.marketscreener.com/quote/stock/IBEX-TECHNOLOGIES-INC-49476936/news/IBEX-Files-Addendum-to-Management-Proxy-Circular-for-Sale-of-the-Company-at-1-45-Per-Share-46168734/?utm_medium=RSS&utm_content=20240314
IBEX is a Canada-based pharmaceutical company that manufactures and markets protein enzyme reagents for in-vitro diagnostics and research applications.